Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the latest version of Genedata Expressionist for Mass Spectrometry (MS) will be showcased at the fifth annual Biotherapeutics Analytical Summit. A data analysis and management platform supporting all MS instrument vendors, Genedata Expressionist for MS eliminates data analysis bottleneck for MS labs. This new version of the software significantly improves MS lab productivity by accelerating the data analysis process for all major biopharmaceutical characterization assays by orders of magnitude compared to common processing procedures. The enterprise-level platform covers all biopharmaceutical applications including: characterization of intact proteins; identification and characterization of post-translational modifications; and characterization and monitoring of impurities in protein samples. Genedata will demonstrate the new Genedata Expressionist for MS at the Biotherapeutics Analytical Summit (Hyatt Regency Baltimore; Booth #2; March 24- 27).
Additionally, a Summit presentation by Sanofi will explore how Genedata Expressionist for MS is used for the in-depth characterization of biotherapeutics based on MS (March 26).
Characterization Projects Completed in Hours vs. Weeks
Mass spectrometry plays an increasingly important role in the characterization of biopharmaceuticals. By providing a vendor-independent and enterprise-level software solution, Genedata Expressionist for MS enables scientists to use the same interface for a variety of MS assays and applications, which reduces the learning curve typically required for different software solutions.
Developed in close collaboration with leading biopharmaceutical companies, the new Genedata Expressionist for MS helps laboratories automate processes across the entire characterization workflow from sample acquisition to result reporting. With intuitive visualizations and exceptional processing power and scalability, Genedata Expressionist enables quick integration and comparison of different experiments, empowering researchers to fully capitalize on their investments in laboratory instrumentation. Customer project times for characterizations are reported to be reduced from three weeks to three hours.
By supporting intact protein analysis, peptide mapping, N- and C-terminal analysis, glycopeptides and released glycans, and prediction of disulphide bonds, Genedata Expressionist for MS helps users with the analysis of the following MS-based applications:
“With Genedata Expressionist for Mass Spectrometry we raise the bar on the analysis of mass spectrometry data and set new standards for the efficient characterization of biopharmaceuticals,” said Dr. Othmar Pfannes, CEO of Genedata. “We are committed to advancing the sofware as the vendor-agnostic platform of choice for the quality assessment of biopharmaceuticals and to making key processes in biopharmaceutical R&D as efficient as possible.”
To find out more about Genedata Expressionist for MS
Visit the website of Expressionist for MS or watch the video on "Characterizing Modifications in Biopharmaceuticals"
Biotherapeutics Analytical Summit Presentation
Session: Analytical Characterization of Biotherapeutics; Wednesday, March 26, 2014; 3:05pm – 3:35pm
Title: “Mass Spectrometry and Software for Structural Characterization of Biotherapeutics”
Author: Juergen Schaefer, Ph.D., Mass Spectrometry Lab Head, Analytical Sciences, LGCR, Sanofi